Targeted HIV testing at birth supported by low and predictable mother-to-child transmission risk in Botswana.

about

Targeted HIV testing at birth supported by low and predictable mother-to-child transmission risk in Botswana.

Item

http://www.wikidata.org/entity/Q55344329

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeted HIV testing at birth ...... transmission risk in Botswana.

@en

Targeted HIV testing at birth ...... transmission risk in Botswana.

@nl

type

Item

label

Targeted HIV testing at birth ...... transmission risk in Botswana.

@en

Targeted HIV testing at birth ...... transmission risk in Botswana.

@nl

prefLabel

Targeted HIV testing at birth ...... transmission risk in Botswana.

@en

Targeted HIV testing at birth ...... transmission risk in Botswana.

@nl

P1476

Targeted HIV testing at birth ...... transmission risk in Botswana.

@en

P2093

Chloe Auletta-Young

http://www.w3.org/2001/XMLSchema#string

Daniel R Kuritzkes

http://www.w3.org/2001/XMLSchema#string

Gbolahan Ajibola

http://www.w3.org/2001/XMLSchema#string

Kenneth Maswabi

http://www.w3.org/2001/XMLSchema#string

Laura Vaughan

http://www.w3.org/2001/XMLSchema#string

Maryanne Ibrahim

http://www.w3.org/2001/XMLSchema#string

Matthias Lichterfeld

http://www.w3.org/2001/XMLSchema#string

Maureen Sakoi

http://www.w3.org/2001/XMLSchema#string

Michael D Hughes

http://www.w3.org/2001/XMLSchema#string

Oganne Batlang

http://www.w3.org/2001/XMLSchema#string

P2860

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment

Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Paediatric HIV infection: the potential for cure.

Early infant diagnosis and outcomes in HIV-exposed infants at a central and a district hospital, Northern Malawi.

Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency.

Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.

HIV testing during the neonatal period.

P304

e25111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JIA2.25111

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Makhema

Shahin Lockman

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29852062

http://www.w3.org/2001/XMLSchema#string

P921

An Bhotsuáin

P932

5980617

http://www.w3.org/2001/XMLSchema#string